Ignite Creation Date:
2024-05-05 @ 11:25 AM
Last Modification Date:
2024-10-26 @ 9:07 AM
Study NCT ID:
NCT00039156
Status:
UNKNOWN
Last Update Posted:
2008-07-24
First Post:
2002-06-06
Brief Title:
BAY 59-8862 in Treating Patients With Refractory Non-Hodgkins Lymphoma
Sponsor:
Theradex
Organization:
National Cancer Institute NCI
Organization Data
Organization:
National Cancer Institute NCI
Class:
NIH
Study ID:
CDR0000069358
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Theradex
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None